EP Patent
EP2081885A2 — Improved processes for preparing venlafaxine base and salts thereof
Assigned to Medichem SA · Expires 2009-07-29 · 17y expired
What this patent protects
The invention relates generally to an improved process for manufacturing venlafaxine base and/or salts thereof.
USPTO Abstract
The invention relates generally to an improved process for manufacturing venlafaxine base and/or salts thereof.
Drugs covered by this patent
- Pristiq (Desvenlafaxine Succinate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.